Hemogenyx Pharmaceuticals (HEMO) Stock Chart & Stock Price History GBX 150.38 +8.13 (+5.72%) As of 10:52 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock Hemogenyx Pharmaceuticals Stock Price Performance The Hemogenyx Pharmaceuticals (HEMO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 10,892.69%, with a year-to-date return of -62.59%. In the past month, the stock has increased 16.57%, reflecting recent market activity. As of the latest close, Hemogenyx Pharmaceuticals traded at GBX 144.28 with a market cap of £5.14 million and volume of 17,066 shares. Five years ago, the stock traded at GBX 9.10, representing a 1,552.53% increase over that period. At the time, it had a market cap of £39.46 million and a volume of 2.38 million shares. Receive HEMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.26%1 Month Performance+16.57%3 Month Performance-15.75%Year-To-Date Performance-62.59%1 Year Performance+10,892.69%5 Year Performance+1,552.53% HEMO Stock Chart for Friday, August, 15, 2025 HEMO Chart by TradingView Hemogenyx Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/14/2025GBX 134.66GBX 144.28+7.14%GBX 144.28GBX 134.2317,066 shs£5.14 million08/13/2025GBX 135.86GBX 134.66-0.88%GBX 141.50GBX 133.0539,189 shs£4.80 million08/12/2025GBX 141.90GBX 135.86-4.26%GBX 144.50GBX 135.8638,936 shs£4.84 million08/11/2025GBX 144.23GBX 141.90-1.62%GBX 148.50GBX 136.7830,047 shs£5.06 million08/08/2025GBX 142GBX 144.23+1.57%GBX 149.50GBX 142.8511,915 shs£5.14 million08/07/2025GBX 150.50GBX 142-5.65%GBX 152.50GBX 14222,226 shs£5.06 million08/06/2025GBX 143.56GBX 150.50+4.84%GBX 153GBX 141.5043,055 shs£5.37 million08/05/2025GBX 145GBX 143.56-1.00%GBX 145GBX 130105,751 shs£5.12 million08/04/2025GBX 156.49GBX 145-7.34%GBX 158.50GBX 142.4656,417 shs£5.17 million08/01/2025GBX 152.50GBX 156.49+2.62%GBX 157.13GBX 150.3814,272 shs£5.58 million Get the Latest News and Ratings for HEMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/31/2025GBX 159.50GBX 152.50-4.39%GBX 159.50GBX 152.503,164 shs£5.44 million07/30/2025GBX 157.85GBX 159.50+1.05%GBX 159.50GBX 152.853,715 shs£5.69 million07/29/2025GBX 167.75GBX 157.85-5.90%GBX 174.50GBX 152.5076,624 shs£5.63 million07/28/2025GBX 179.36GBX 167.75-6.47%GBX 183GBX 16642,995 shs£5.98 million07/25/2025GBX 173GBX 179.36+3.68%GBX 182.50GBX 17218,719 shs£6.39 million07/24/2025GBX 180GBX 173-3.89%GBX 182.50GBX 172.5015,268 shs£6.17 million07/23/2025GBX 176.25GBX 180+2.13%GBX 182GBX 172.5068,279 shs£6.42 million07/22/2025GBX 148.98GBX 176.25+18.30%GBX 183GBX 141.50143,440 shs£6.28 million07/21/2025GBX 129.48GBX 148.98+15.06%GBX 150GBX 14528,390 shs£5.31 million07/18/2025GBX 133.50GBX 129.48-3.01%GBX 135.17GBX 129.4817,512 shs£4.62 million07/17/2025GBX 131.38GBX 133.50+1.62%GBX 133.50GBX 127.806,569 shs£4.76 million07/16/2025GBX 129GBX 131.38+1.84%GBX 133.43GBX 131.1548,595 shs£4.68 million07/15/2025GBX 144.10GBX 129-10.48%GBX 144.50GBX 124.27151,408 shs£4.60 million07/14/2025GBX 144.28GBX 144.10-0.12%GBX 145GBX 139.7538,303 shs£5.14 million Related Companies Sareum Stock Price Chart Fusion Antibodies Stock Price Chart Poolbeg Pharma Stock Price Chart IXICO Stock Price Chart Aptamer Group Stock Price Chart OptiBiotix Health Stock Price Chart Oxford BioDynamics Stock Price Chart Synairgen Stock Price Chart ImmuPharma Stock Price Chart Cizzle Biotechnology Stock Price Chart Receive HEMO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:HEMO) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hemogenyx Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hemogenyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.